|
GNAI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.717500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.324640E-01 |
| Normal-vs-Stage2 |
1.922440E-01 |
| Normal-vs-Stage3 |
7.006900E-04 |
| Normal-vs-Stage4 |
1.821800E-01 |
| Stage1-vs-Stage2 |
9.833200E-01 |
| Stage1-vs-Stage3 |
1.609930E-02 |
| Stage1-vs-Stage4 |
8.386800E-01 |
| Stage2-vs-Stage3 |
8.677800E-02 |
| Stage2-vs-Stage4 |
8.438400E-01 |
| Stage3-vs-Stage4 |
1.991210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.030610E-01 |
| Normal-vs-AfricanAmerican |
7.889800E-02 |
| Normal-vs-Asian |
1.470760E-01 |
| Caucasian-vs-AfricanAmerican |
9.473400E-01 |
| Caucasian-vs-Asian |
5.928800E-01 |
| AfricanAmerican-vs-Asian |
5.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.789800E-02 |
| Normal-vs-Female |
1.684010E-01 |
| Male-vs-Female |
6.920600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.038700E-03 |
| Normal-vs-Extreme_Weight |
1.862350E-01 |
| Normal-vs-Obese |
1.310760E-01 |
| Normal-vs-Extreme_Obese |
7.179700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.056370E-01 |
| Normal_Weight-vs-Obese |
1.590650E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.392000E-01 |
| Extreme_Weight-vs-Obese |
8.131800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.866800E-01 |
| Obese-vs-Extreme_Obese |
4.694400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.967500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.733600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.836800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.825800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.067800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.678200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.327600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.200600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.702200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.140800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.917000E-01 |
| Normal-VS-Type2 PRCC |
3.32000000047294E-07 |
| Normal-VS-KIRP CIMP |
1.119690E-02 |
| Normal-VS-Unclassified PRCC |
8.791700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.4432899320127E-15 |
| Type1 PRCC-VS-KIRP CIMP |
1.244690E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.892000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.853200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.387300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.729240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.016050E-04 |
| Normal-vs-N1 |
8.819600E-04 |
| Normal-vs-N2 |
3.369400E-01 |
| N0-vs-N1 |
8.892800E-01 |
| N0-vs-N2 |
4.691200E-01 |
| N1-vs-N2 |
4.241600E-01 |
|
|
